World Journal of Gastrointestinal Pathophysiology

TSC-mTOR pathway in human disease. Nat Genet 2005; 37:
19-24
16 Khamzina L, Veilleux A, Bergeron S, Marette A. Increased
activation of the mammalian target of rapamycin pathway in
liver and skeletal muscle of obese rats: possible involvement
in obesity-linked insulin resistance. Endocrinology 2005; 146:
1473-1481
17 Um SH, Frigerio F, Watanabe M, Picard F, Joaquin M, Sticker
M, Fumagalli S, Allegrini PR, Kozma SC, Auwerx J, Thomas
G. Absence of S6K1 protects against age- and diet-induced
obesity while enhancing insulin sensitivity. Nature 2004; 431:
200-205
18 Blanco Martínez de Morentin P, González CR, Saha AK,
Martins L, Diéguez C, Vidal-Puig A, Tena-Sempere M, López
M. Hypothalamic AMP-activated protein kinase as a mediator
of whole body energy balance. Rev Endocr Metab Disord
2011; 12: 127-140
19 Inoki K, Zhu T, Guan KL. TSC2 mediates cellular energy
response to control cell growth and survival. Cell 2003; 115:
577-590
20 Xu G, Li Y, An W, Zhao J, Xiang X, Ding L, Li Z, Guan Y,
Wang X, Tang C, Zhu Y, Wang N, Li X, Mulholland M,
Zhang W. Regulation of gastric hormones by systemic rapamycin.
Peptides 2010; 31: 2185-2192
21 Wilson BS, Lloyd RV. Detection of chromogranin in neuroendocrine
cells with a monoclonal antibody. Am J Pathol
1984; 115: 458-468
22 Bajetta E, Ferrari L, Martinetti A, Celio L, Procopio G, Artale
S, Zilembo N, Di Bartolomeo M, Seregni E, Bombardieri E.
Chromogranin A, neuron specific enolase, carcinoembryonic
antigen, and hydroxyindole acetic acid evaluation in patients
with neuroendocrine tumors. Cancer 1999; 86: 858-865
23 Dockray GJ, Varro A, Dimaline R. Gastric endocrine cells:
gene expression, processing, and targeting of active products.
Physiol Rev 1996; 76: 767-798
24 Kojima M, Kangawa K. Ghrelin: structure and function.
Physiol Rev 2005; 85: 495-522
25 Kojima M, Hosoda H, Date Y, Nakazato M, Matsuo H, Kangawa
K. Ghrelin is a growth-hormone-releasing acylated
peptide from stomach. Nature 1999; 402: 656-660
26 Date Y, Kojima M, Hosoda H, Sawaguchi A, Mondal MS, Suganuma
T, Matsukura S, Kangawa K, Nakazato M. Ghrelin, a
novel growth hormone-releasing acylated peptide, is synthesized
in a distinct endocrine cell type in the gastrointestinal
tracts of rats and humans. Endocrinology 2000; 141: 4255-4261
27 Zhang JV, Ren PG, Avsian-Kretchmer O, Luo CW, Rauch
R, Klein C, Hsueh AJ. Obestatin, a peptide encoded by the
ghrelin gene, opposes ghrelin’s effects on food intake. Science
2005; 310: 996-999
28 Yang J, Brown MS, Liang G, Grishin NV, Goldstein JL. Identification
of the acyltransferase that octanoylates ghrelin, an
appetite-stimulating peptide hormone. Cell 2008; 132: 387-396
29 Gutierrez JA, Solenberg PJ, Perkins DR, Willency JA, Knierman
MD, Jin Z, Witcher DR, Luo S, Onyia JE, Hale JE. Ghrelin
octanoylation mediated by an orphan lipid transferase.
Proc Natl Acad Sci USA 2008; 105: 6320-6325
30 Gil-Campos M, Aguilera CM, Cañete R, Gil A. Ghrelin: a
hormone regulating food intake and energy homeostasis. Br
J Nutr 2006; 96: 201-226
31 Heppner KM, Tong J, Kirchner H, Nass R, Tschöp MH. The
ghrelin O-acyltransferase-ghrelin system: a novel regulator
of glucose metabolism. Curr Opin Endocrinol Diabetes Obes
2011; 18: 50-55
32 Nakazato M, Murakami N, Date Y, Kojima M, Matsuo H,
Kangawa K, Matsukura S. A role for ghrelin in the central
regulation of feeding. Nature 2001; 409: 194-198
33 Asakawa A, Inui A, Kaga T, Katsuura G, Fujimiya M, Fujino
WJGP|www.wjgnet.com
Xu GY et al . mTOR and gastric hormones
MA, Kasuga M. Antagonism of ghrelin receptor reduces food
intake and body weight gain in mice. Gut 2003; 52: 947-952
34 Carlson MJ, Cummings DE. Prospects for an anti-ghrelin
vaccine to treat obesity. Mol Interv 2006; 6: 249-252
35 Helmling S, Maasch C, Eulberg D, Buchner K, Schröder W,
Lange C, Vonhoff S, Wlotzka B, Tschöp MH, Rosewicz S,
Klussmann S. Inhibition of ghrelin action in vitro and in vivo
by an RNA-Spiegelmer. Proc Natl Acad Sci USA 2004; 101:
13174-13179
36 Chen HY, Trumbauer ME, Chen AS, Weingarth DT, Adams
JR, Frazier EG, Shen Z, Marsh DJ, Feighner SD, Guan XM, Ye
Z, Nargund RP, Smith RG, Van der Ploeg LH, Howard AD,
MacNeil DJ, Qian S. Orexigenic action of peripheral ghrelin
is mediated by neuropeptide Y and agouti-related protein.
Endocrinology 2004; 145: 2607-2612
37 Cummings DE, Purnell JQ, Frayo RS, Schmidova K, Wisse
BE, Weigle DS. A preprandial rise in plasma ghrelin levels
suggests a role in meal initiation in humans. Diabetes 2001;
50: 1714-1719
38 Tschöp M, Weyer C, Tataranni PA, Devanarayan V, Ravussin
E, Heiman ML. Circulating ghrelin levels are decreased
in human obesity. Diabetes 2001; 50: 707-709
39 Cummings DE, Clement K, Purnell JQ, Vaisse C, Foster KE,
Frayo RS, Schwartz MW, Basdevant A, Weigle DS. Elevated
plasma ghrelin levels in Prader Willi syndrome. Nat Med
2002; 8: 643-644
40 Date Y, Nakazato M, Hashiguchi S, Dezaki K, Mondal MS,
Hosoda H, Kojima M, Kangawa K, Arima T, Matsuo H, Yada
T, Matsukura S. Ghrelin is present in pancreatic alpha-cells
of humans and rats and stimulates insulin secretion. Diabetes
2002; 51: 124-129
41 Dezaki K, Hosoda H, Kakei M, Hashiguchi S, Watanabe
M, Kangawa K, Yada T. Endogenous ghrelin in pancreatic
islets restricts insulin release by attenuating Ca2+ signaling
in beta-cells: implication in the glycemic control in rodents.
Diabetes 2004; 53: 3142-3151
42 Sun Y, Asnicar M, Saha PK, Chan L, Smith RG. Ablation of
ghrelin improves the diabetic but not obese phenotype of
ob/ob mice. Cell Metab 2006; 3: 379-386
43 Kim MS, Yoon CY, Park KH, Shin CS, Park KS, Kim SY,
Cho BY, Lee HK. Changes in ghrelin and ghrelin receptor
expression according to feeding status. Neuroreport 2003; 14:
1317-1320
44 Edkins JS. The chemical mechanism of gastric secretion. J
Physiol 1906; 34: 133-144
45 SMITH AN. Gastrin and histamine release. J Physiol 1954;
123: 71P-72P
46 Ekundayo AA, Lee CY, Goodlad RA. Gastrin and the growth
of the gastrointestinal tract. Gut 1995; 36: 203-208
47 Sachs G, Zeng N, Prinz C. Physiology of isolated gastric endocrine
cells. Annu Rev Physiol 1997; 59: 243-256
48 Uvnäs-Wallenstein K, Uvnäs B, Nilsson G. Quantitative
aspects of the vagal control of gastrin release in cats. Acta
Physiol Scand 1976; 96: 19-28
49 Ling N, Burgus R, Rivier J, Vale W, Brazeau P. The use of
mass spectrometry in deducing the sequence of somatostatin--a
hypothalamic polypeptide that inhibits the secretion
of growth hormone. Biochem Biophys Res Commun 1973; 50:
127-133
50 Raptis S, Dollinger HC, von Berger L, Schlegel W, Schröder
KE, Pfeiffer EF. Effects of somatostatin on gastric secretion
and gastrin release in man. Digestion 1975; 13: 15-26
51 Levin BE, Routh VH, Kang L, Sanders NM, Dunn-Meynell
AA. Neuronal glucosensing: what do we know after 50
years? Diabetes 2004; 53: 2521-2528
52 Blouet C, Ono H, Schwartz GJ. Mediobasal hypothalamic
p70 S6 kinase 1 modulates the control of energy homeostasis.
Cell Metab 2008; 8: 459-467
S- Editor Wu X L- Editor Roemmele A E- Editor Zheng XM
113 December 15, 2011|Volume 2|Issue 6|